These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18845558)

  • 1. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
    Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
    Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
    Fu F; Wang C; Huang M; Song C; Lin S; Huang H
    Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
    Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
    Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
    Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
    Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
    Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
    Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
    PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations.
    Barzan D; Veldwijk MR; Herskind C; Li Y; Zhang B; Sperk E; Du WD; Zhang XJ; Wenz F
    Eur J Hum Genet; 2013 Nov; 21(11):1286-92. PubMed ID: 23486537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality.
    Chen F; Lu M; Xue Y; Zhou J; Hu F; Chen X; Zhao Z; Li Y; Wang X
    Immunogenetics; 2012 Jan; 64(1):71-6. PubMed ID: 21822685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
    Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA
    Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.
    Liang J; Chen P; Hu Z; Shen H; Wang F; Chen L; Li M; Tang J; Wang H; Shen H
    Breast Cancer Res Treat; 2010 Nov; 124(1):237-41. PubMed ID: 20213080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
    Wang H; Yang Z; Zhang H
    Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
    Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women.
    Liang H; Yang X; Chen L; Li H; Zhu A; Sun M; Wang H; Li M
    Biomed Res Int; 2015; 2015():626948. PubMed ID: 26421298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan.
    Kawase T; Matsuo K; Suzuki T; Hiraki A; Watanabe M; Iwata H; Tanaka H; Tajima K
    Int J Cancer; 2009 Oct; 125(8):1946-52. PubMed ID: 19582883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
    Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
    Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
    Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
    Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
    Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.
    Elgazzar S; Zembutsu H; Takahashi A; Kubo M; Aki F; Hirata K; Takatsuka Y; Okazaki M; Ohsumi S; Yamakawa T; Sasa M; Katagiri T; Miki Y; Nakamura Y
    J Hum Genet; 2012 Dec; 57(12):766-71. PubMed ID: 22951594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.